Maria B. Panarotto
Brescia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The role of Hashimoto thyroiditis in predicting radioiodine ablation efficacy and prognosis of low to intermediate risk differentiated thyroid cancer.
Journal: Annals of nuclear medicine
Published: March 17, 2021
Incidental Findings Suggestive of COVID-19 in Asymptomatic Patients Undergoing Nuclear Medicine Procedures in a High-Prevalence Region.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 31, 2020
Three years' clinical practice of Radium-223 therapy in patients with symptomatic bone metastases from metastatic castrate-resistant prostate cancer: a single-centre experience.
Journal: Nuclear medicine communications
Published: February 13, 2020
Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines.
Journal: European journal of endocrinology
Published: March 28, 2018
Early and late adverse effects of radioiodine for pediatric differentiated thyroid cancer.
Journal: Pediatric blood & cancer
Published: January 09, 2017
Differentiated thyroid carcinoma: Incremental diagnostic value of 131I SPECT/CT over planar whole body scan after radioiodine therapy.
Journal: Endocrine
Published: May 03, 2016
A follow-up ¹⁸F-FDG brain PET study in a case of Hashimoto's encephalopathy causing drug-resistant status epilepticus treated with plasmapheresis.
Journal: Journal of neurology
Published: September 25, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026